The 2018 NIH Innovation Conference will be held on October 23rd, 2018 at the SUNY Global Center in midtown Manhattan.
The meeting will provide investment-ready small businesses funded by NIH with pitch coaching and networking with experienced life science business professionals to prepare them for the Life Sciences Summit the following day. The Life Sciences Summit a premier biotech conference in NYC that includes company pitches to pharma and MedTech executives and investors, one-on-one partnering meetings, and panel discussions on topics relevant to early-stage companies.
- Aronora, Inc.
- Allosteros Therapeutics, Inc.
- Avery Therapeutics, Inc.
- CardioCreate, Inc.
- Celdara Medical, LLC
- Elex Biotech LLC
- Jamboxx, Inc.
- Madeleine Pharmaceuticals, Inc.
- Novo Biosciences, Inc.
- PharmaIN, Corp.
- Venarum Medical, LLC
- Windmill Cardiovascular Systems, Inc.
- Aavogen, Inc.
- ADT Pharmaceuticals, LLC
- CuronBiotech, Inc.
- Inhibikase Therapeutics, Inc.
- Kiromic, Inc.
- Organix, Inc.
The 2018 NIH Innovation Conference is organized by the National Heart, Lung, and Blood Institute (NHLBI) and the National Cancer Institute (NCI). Small businesses funded by these institutes will be on hand to showcase the latest in early-stage biomedical products developed with non-dilutive federal grant and contract funding.
For questions about the 2018 NIH Innovation Conference please contact Steve Flaim.
- National Heart, Lung, and Blood Institute (NHLBI)
- National Cancer Institute (NCI)